首页> 外文期刊>Journal of Drug Delivery and Therapeutics >“IN-VITRO EVALUATION OF IMMUNOMODULATORY EFFECT OF POLYHERBAL COMPOUND - BHARANGYADI”.
【24h】

“IN-VITRO EVALUATION OF IMMUNOMODULATORY EFFECT OF POLYHERBAL COMPOUND - BHARANGYADI”.

机译:“多药化合物-勃朗雅迪的免疫调节作用的体外评估”。

获取原文
           

摘要

Bharangyadi compound is a polyherbal drug use in Ayurveda system of medicine for the management of allergic disoders such as allergic rhinitis, allergic asthma etc. The present study was carried out to evaluate the immunomodulatory activity of ethanolic extract of polyherbal compound “ Bharangyadi” on swiss albino mice. Cyclophosphamide induced immunosuppression model was used to assess the activity of drug. Cyclophosphamide was given in the dose of 30mg/kg body weight through i.p route. 500mg/kg body weight of Bharangyadi polyherbal drug was given through oral route. The extent of protection against immunosuppression caused by Cyclophosphsmide was evaluated after 14 days of drug administration, by estimating hematological parameter and neutrophil adhesion test. Ethanolic extracts of Bharangyadi Compound showed pronounced immunoprotective activity by increasing the depleted levels of total WBC count and RBC, % Hb, and % neutrophils adhesion.The extract was found to be an effective immunomodulatory agent.
机译:Bharangyadi化合物是Ayurveda系统中用于治疗过敏性疾病(如过敏性鼻炎,过敏性哮喘等)的多草药药物。本研究旨在评估多草药化合物“ Bharangyadi”的乙醇提取物对瑞士白化病的免疫调节活性。老鼠。用环磷酰胺诱导的免疫抑制模型评估药物的活性。通过腹膜内途径给予环磷酰胺,剂量为30mg / kg体重。通过口服途径给予500mg / kg体重的Bharangyadi多草药药物。药物给药14天后,通过评估血液学参数和中性粒细胞粘附试验,评估了针对环磷酰胺引起的免疫抑制的保护程度。 Bharangyadi化合物的乙醇提取物通过增加WBC总数和RBC的消耗水平,%Hb和中性粒细胞黏附度的降低水平而表现出明显的免疫保护活性,被发现是一种有效的免疫调节剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号